< Our Providers
IMPORTANT NOTICE:
Dr. Peckham's clinic is currently booking out 9 months for new patient referrals.  We have an unprecedented number of referrals at this time due to the transition of 3 movement disorder doctors in Austin retiring/leaving/ or moving to a concierge model. As you are waiting to be seen, please contact your primary care doctor for any refill of medications. Legally, our clinic cannot fill medications for you until you are an established patient in the practice.  
​We appreciate your patience.
Dr. Peckham's Medical Assistant
​​Cyndel Arroyo, Ext. 211
Dr. Peckham specializes in the diagnosis and treatment of movement disorders such as Parkinson's disease, Parkinsonism, Essential tremor, Myoclonus, Tourette's syndrome/Tics, Ataxia, Dystonia, Restless Legs Syndrome (RLS), Huntington's disease, Tardive Dyskinesia, and Psychogenic movement disorders.  Dr. Peckham also has extensive experience with the evaluation for and programming of deep brain stimulators and botulinum toxin injections.

Experience and Education

  • Board Certified in Neurology by the American Board of Psychiatry and Neurology, 2005
  • Movement Disorder Specialist, Central Texas Neurology Consultants:  February 2014-present
  • Neurologist, Darnall Army Medical Center, Fort Hood, TX:  2012-2013
  • Movement Disorder Specialist, Neurology Specialists of Dallas, Dallas, TX:  2007-2012
  • Fellowship, Movement Disorders, National Institutes of Health, Bethesda, MD:  2004-2007
  • Residency, Neurology, Georgetown University, Washington, DC:  2001-2004
  • Internship, Internal Medicine, UT San Antonio, San Antonio, TX:  2000-2001
  • Medical Education:  University of North Texas Health Science Center- Texas College of Osteopathic Medicine, Ft. Worth, TX:  1996-2000

Honors and Awards

  • Mavern Devine Kinzie Scholarship, 1998
  • Resident Scholarship, American Academy of Neurology Annual Meeting, 2003
  • Chief Resident in Neurology, Georgetown University, 2004
  • Young Scientists Best Poster Series, Movement Disorder Society International Meeting, 2006
  • NIH Clinical Center Clinical Research Curriculum Certificate with Commendation, 2007
  • Medical Advisory Board, Parkinson Voice Project

Research Interests

  • Clinical Fellowship Research, Human Motor Control Section, NIH

    Clinical  Developed expertise in diagnosing and treating movement disorders including Parkinson disease, essential tremor, ataxia, dystonia, restless legs syndrome and psychogenic movement disorders.  Proficient in procedures including: EMG-guided botulinum toxin injections (for dystonia {cervical, focal hand, leg and blepharospasm}, hemifacial spasm, and spasticity due to stroke) and DBS programming. 

    Research  Specific research interests include: 1) genetic studies in focal dystonia and Parkinson disease, from the protocol planning and patient population selection to the hospital- and community-based collection of patient data and samples; 2) blink reflex recording and analysis; 3) visual and respiratory biofeedback; and 3) neurophysiologic recording and analysis of tremor and myoclonus.
  • Co-Investigator CARISEPY Study, Ortho-McNeill-Jansen: 10/2007 - 6/2008
  • Co-Investigator ANS/ St. Jude Study for deep brain stimulation in Parkinson’s disease and essential tremor: 10/2007 - 7/2012

Publications

Peckham EL, Giblen G, Kim AK, Sirdofsky MD.  “Bilateral Extraocular Metastases from Primary Breast Cancer” Neurology 2005 Jul 12; 65 (1):  74
  • Elble R, the Tremor Research Group and Conference Attendees (Peckham, E).  Report from a US conference on essential tremor.  Movement Disorders 2006 Dec;21(12): 2052-61
  • Fung HC, Sholz S, Matarin M, Simon-Sanchez J, Hernandez D, Britton A, Gibbs JR, Langefeld C, Stiegert ML, Schymick J, Okun MS, Mandel RJ, Fernandez JJ, Foote KD, Rodriguez RL, Peckham E, DeVrieze FW, Gwinn-Hardy K, Hardy JA, Singleton A.  Genome-wide genotyping in Parkinson’s disease and neurologically normal controls:  first stage analysis and public release of data.  Lancet Neurol 2006 Nov 5
  • Simon-Sanchez J, Sholz S, Fung HC, Matarin M, Hernandez G, Gibbs JR, Britton A, De Vrieze FW, Peckham E, Gwinn-Hardy K, Crawley A, Keen JC, Nash J, Borgaonkar D, Hardy J, Singleton A.  Genome-wide SNP assay reveals structural genomic variation, extended homozygosity and cell-line induced alterations in normal individuals.  Hum Mol Genet 2007 Jan 1; 16(1): 1-14
  • Clarimon J, Brancati F, Peckham E, Valente EM, Dallapiccola B, Abruzzese G, Girlanda P, Defazio G, Beradella A, Hallett M, Singleton AB.  Assessing the role of DRD5 and DYT-1 in two different case control series with primary blepharospasm.  Mov Disor 2007 Feb 22 (2):  162-66
  • Goldstein DS, Imrich R, Peckham E, Holmes C, Lopez G, Crews C, Hardy J, Singleton A, Hallett M.  Cardiac Sympathetic Denervation, Baroreflex Failure, and Nigrostriatal Dopamine Deficiency in Parkinson Disease from LRRK2 Gene Mutation. Neurology 2007 Oct 16; 69 (16):  1580-4
  • Nahab FB, Peckham EL, Hallett M.  Essential tremor, deceptively simple….Pract Neurol 2007 Aug 7 (4) 222-33.
  • Nahab FB, Peckham EL, Hallett M.  Double- blind, placebo-controlled, pilot trial of botulinum toxin A in restless legs syndrome.  Neurology 2008 Sept 16; 71 (12):  950-1.
  • Hallett M, Evinger C, Jankovic J, Stacy M (Peckham E).  Update on Blepharospasm:  A report from the BEBRF International Workshop.  Neurology 2008 Oct 14; 17(16): 1275-82.
  • DeFazio G, Matarin M, Peckham EL, Martino D, Valente EM, Singleton A, Crawley A, Aniello MS, Brancati F, Abbruzzese G, Girlanda P, Livrea P, Hallett M, Beradelli A.  The TOR1A polymorphism rs1182 and the risk of spread in primary blepharospasm.  Mov Disord 2009 Mar 15;24(4):613-6.
  • Peckham EL, Lopez G, Shamim E, Pirio Richardson S, Sanku S, Malkani R, Stacy M, Mahant P, Crawley A, Singleton A, Hallett, M  Clinical Features of Patients with Blepharospasm:  A Report of 240 Cases. Eu J Neurol 2011 Mar;18(3):382-6


 Abstracts
  • Stewart M, Kondraske G, Peckham EL.  Nonlinear Causal Resource Analysis (NCRA) of Hierarchical Relationship for Balance, Coordination, and Cognitive Components of Gait in Parkinson’s Disease (PD).  The 3rd International Congress on Gait and Mental Function.  Washington, DC.  Feb 2010
  • Peckham EL, Lin PT, Shamim EA, Hallett M.  Exercise as an Environmental Trigger for Focal Dystonia.  International Movement Disorder Meeting, Istanbul Turkey, June 2007 
  • Peckham, EL, Slagle E, Tzatha E, Murat A, Leon-Sarmiento F, Hallett M, Bara-Jimenez W.  Sensorimotor Gating is Abnormal in Primary Restless Legs Syndrome.  International Movement Disorder Meeting, Kyoto Japan, October 2006.
  • Pirio Richardson S, Matsuhashi M, Voon V, Peckham E, Nahab F, Mari Z, Maguire S, Matteson S, Apud J, Hallett M.  Timing of the sense of volition in patients with schizophrenia.  (Presented by Dr. Pirio Richardson as oral presentation at the 28th International Congress of Clinical Neurophysiology in Edinburgh, Scotland, 10-14 September 2006).

 Invited reviews/chapters
  • Peckham, E, Karp, B.  “Abetalipoproteinemia” in Reich, S. (ed), Movement Disorders: 100 Instructive Cases.” Taylor & Francis Books Ltd., 2008 
  • Karp, B.  Peckham, E.  “ A 33 year old male with progressive chorea and behavioral changes” in Reich, S. (ed), Movement Disorders: 100 Instructive Cases.” Taylor & Francis Books Ltd., 2008
  • Peckham, EL, Hallett M.  Psychogenic Movement Disorders in Hallett, M and Poewe W (ed), Therapeutics of Parkinson’s and Other Movement Disorders, 2008 
  • Peckham, EL, Hallett M.  Psychogenic Movement Disorders, Neurol Clin. 2009 Aug;27(3):801-19, vii.
Testimonials
- call us at -
512-218-1222
16040 Park Valley Dr, Building B, Suite 100 | Round Rock, TX 78681 | Phone (512)218-1222 | Fax (512)218-1393
Central Texas Neurology Consultants, PA  ©2023
Contact  |  Privacy Policy  |  Pay Online